aztreonam
active ingredient
azactam
injection
overall incidence of systemic side effects
aztreonam
active ingredient
azactam
inhalation
cough
nasal congestion
wheezing
bronchospasm postmarketing reports
dyspneaaztreonam for injection
dyspnea
chest pain
sneezing
nasal congestion
aztreonam
active ingredient
azactam
inhalation
pyrexia
pharyngolaryngeal pain
chest discomfort
abdominal pain aztreonam for injection
superinfection
weakness
fever
malaise
flushing
superinfection
patients during aztreonam therapy
enterococcus
staphylococcus
onset of pseudomembranous colitis symptoms
antibiotic treatment
aztreonam for inhalation
vomiting aztreonam for injection
nausea
vomiting
diarrheauncommon
abdominal cramps
mouth ulcer
altered taste
numb tongue
halitosisrare
clostridium difficile
associated diarrhea
pseudomembranous colitis
gastrointestinal bleeding
toxic epidermal necrolysis
aztreonam
active ingredient
azactam
ill patients on many other medications
making implication of aztreonam
aztreonam for inhalation
rash aztreonam for injection
rash
toxic epidermal necrolysis
purpura
erythema multiforme
exfoliative dermatitis
urticaria
petechiae
pruritus
diaphoresis
aztreonam
active ingredient
azactam
injection
discomfort/swelling at the injection site after intramuscular administration
phlebitis/thrombophlebitis after intravenous administration
widespread maculopapular eruption
hours
receiving aztreonam
active ingredient
azactam
corticosteroids
antihistamines
reaction
days
patient
cross-reactivity
ceftazidime
same side chain as aztreonam
aztreonam for inhalation
frequency
allergic reaction
facial rash
facial swelling
throat tightness
aztreonam for injection
anaphylaxis
angioedema
bronchospasmrare
maculopapular eruption
least case
case of myelosuppression
aztreonam
active ingredient
azactam
many other drugs
patient
implication of aztreonam as the causative agent
studies
aztreonam
adp-induced platelet aggregation at high concentrations
therapeutic doses of aztreonam
bleeding problems
aztreonam for injection
pancytopenia
neutropenia
thrombocytopenia
anemia
eosinophilia
leukocytosis
thrombocytosisfrequency
increased prothrombin time
partial thromboplastin time
positive coombs
test
aztreonam
active ingredient
azactam
injection
hepatitis
jaundice
signs
symptoms of hepatobiliary dysfunctionfrequency
elevated ast
elevated alt
elevated alkaline phosphatase
aztreonam
active ingredient
azactam
injection
hypotension
transient electrocardiogram changes
ventricular bigeminy
premature ventricular contractions
aztreonam
active ingredient
azactam
injection
seizure
headache
confusion
vertigo
paresthesia
insomnia
dizziness
tinnitus
aztreonam
active ingredient
azactam
inhalation
postmarketing reports
arthralgia
joint swellingaztreonam for injection
muscular aches
aztreonam
active ingredient
azactam
injection
acute interstitial nephritis
least case
frequency
increased serum creatinine
acute interstitial nephritis
aztreonam
ill patient
receiving many other medications
aztreonam
active ingredient
azactam
injection
vaginal candidiasis
vaginitis
breast tenderness
aztreonam
active ingredient
azactam
injection
diplopia
powder for solution
solution
chest discomfort
cough
difficulty with breathing
troubled breathing
fever
noisy breathing
shortness of breath
tightness in the chest
stomach pain
sore throat
stuffy nose
vomiting
rash